Notably, amelioration of APAP-induced liver disease by administration of recombinant IL-2234, 35 associated with modulation of hepatic IL-36γ (Fig. 1a), suggesting that expression of IL-36γ may link to disease severity. The gene discussed is IL36G; the disease is liver disorder.